COMPASSION 3: Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the

Grants and Contracts Details

StatusFinished
Effective start/end date9/7/167/26/24

Funding

  • Edwards Lifesciences: $77,092.00